Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Cash from Investing Activities (2021 - 2026)

MoonLake Immunotherapeutics' Cash from Investing Activities history spans 6 years, with the latest figure at $98000.0 for Q1 2026.

  • Quarterly Cash from Investing Activities fell 99.83% to $98000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $146.8 million through Mar 2026, up 221.82% year-over-year, with the annual reading at $203.0 million for FY2025, 198.73% up from the prior year.
  • Cash from Investing Activities came in at $98000.0 for Q1 2026, up from -$29.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $116.9 million in Q4 2023 to a low of -$174.4 million in Q3 2023.
  • The 5-year median for Cash from Investing Activities is $98000.0 (2026), against an average of -$3.5 million.
  • Year-over-year, Cash from Investing Activities crashed 362386.24% in 2022 and then skyrocketed 633802550.0% in 2023.
  • MoonLake Immunotherapeutics' Cash from Investing Activities stood at $9.9 million in 2022, then soared by 1080.3% to $116.9 million in 2023, then crashed by 226.07% to -$147.3 million in 2024, then soared by 79.7% to -$29.9 million in 2025, then soared by 100.33% to $98000.0 in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Cash from Investing Activities are $98000.0 (Q1 2026), -$29.9 million (Q4 2025), and $88.4 million (Q3 2025).